Jean Dubuisson, François-Loïc Cosset  Journal of Hepatology 

Slides:



Advertisements
Similar presentations
THE REPLICATION OF VIRUSES Virology Lecture 2 Three lectures dealing with (1) replication of DNA viruses (2) the culture, growth and recognition of virus.
Advertisements

General Principles De novo initiation: – RNA polymerase – RNA template – The initiating NTP and a second NTP Primer Dependant initiation – Protein primer.
Biochemistry of Hepatitis C
EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep
Retroviruses - Retroviridae
Flaviviridae Positive stranded RNA viruses. Flaviviridae Enveloped virions made up of a lipid bilayer with two or more types of envelope (E) glycoproteins.
Laurent Mailly, Mirjam B. Zeisel, Thomas F. Baumert 
Domenico Sansonno, Franco Dammacco  The Lancet Infectious Diseases 
Hepatitis C virus: life cycle in cells, infection and host response, and analysis of molecular markers influencing the outcome of infection and response.
Jean Dubuisson, François-Loïc Cosset  Journal of Hepatology 
Positive stranded RNA viruses
Roles of Lipoproteins and Apolipoproteins in Particle Formation of Hepatitis C Virus  Takasuke Fukuhara, Chikako Ono, Francesc Puig-Basagoiti, Yoshiharu.
Structural biology of hepatitis C virus
Hepatitis C Virus NS5A Protein–A Master Regulator?
Objectives To understand the general principles involved in RNA replication discussed in Chapter 6 pages To use the following + stranded RNA viruses.
VIRAL GENE EXPRESSION DR.SOBIA MANZOOR LECTURE 05.
Occult Hepatitis C Virus Infection: Are We Digging Too Deep?
Hepatitis C virus infection
Hepatitis C virus: life cycle in cells, infection and host response, and analysis of molecular markers influencing the outcome of infection and response.
Mirjam B. Zeisel, Isabel Fofana, Samira Fafi-Kremer, Thomas F. Baumert 
Matthew T. Kitson, Stuart K. Roberts  Journal of Hepatology 
Volume 47, Issue 1, Pages (July 2007)
NS5A inhibitors in the treatment of hepatitis C
HCV NS5A Inhibitors: The Devil Is in the Details
Immigration and viral hepatitis
Figure 1 HCV life cycle and site of action of DAAs
Hepatitis C Virus NS5A Protein–A Master Regulator?
Hepatitis C virus entry and glucocorticosteroids
HCV and the hepatic lipid pathway as a potential treatment target
Mechanisms of HBV-related hepatocarcinogenesis
Natural history and predictors of severity of chronic hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection  Anaïs Vallet-Pichard,
Type A viral hepatitis: A summary and update on the molecular virology, epidemiology, pathogenesis and prevention  Stanley M. Lemon, Jördis J. Ott, Pierre.
Volume 61, Issue 2, Pages (August 2014)
Hepatitis C core protein – The “core” of immune deception?
Emerging Therapeutic Targets for Hepatitis C Virus Infection
Volume 61, Issue 1, Pages S108-S119 (November 2014)
David Paul, Vanesa Madan, Ralf Bartenschlager  Cell Host & Microbe 
Volume 44, Issue 2, Pages (February 2006)
RNAi – A powerful tool to unravel hepatitis C virus–host interactions within the infectious life cycle  Joachim Lupberger, Laurent Brino, Thomas F. Baumert 
Volume 61, Issue 1, Pages S69-S78 (November 2014)
Daniel J. Felmlee, Thomas F. Baumert  Journal of Hepatology 
Hepatitis C virus–cell interactions and their role in pathogenesis
Darius Moradpour, Arash Grakoui, Michael P. Manns 
Autophagy in the liver Journal of Hepatology
Host-targeting agents for prevention and treatment of chronic hepatitis C – Perspectives and challenges  Mirjam B. Zeisel, Joachim Lupberger, Isabel Fofana,
Volume 61, Issue 1, Pages S45-S57 (November 2014)
Steroid hormones: Interactions with membrane-bound receptors
Replication of human astroviruses.
Breaking the Barrier: Host Cell Invasion by Lujo Virus
Protein interactions during the flavivirus life cycle elucidated by MS-based proteomics. Protein interactions during the flavivirus life cycle elucidated.
Pathogenesis of Flavivirus Infections: Using and Abusing the Host Cell
Interferon-Free Treatment Regimens for Hepatitis C: Are We There Yet?
The role of quantitative hepatitis B surface antigen revisited
Hepatitis C virus: life cycle in cells, infection and host response, and analysis of molecular markers influencing the outcome of infection and response.
New therapies on the horizon for hepatitis C
Michael S. Diamond, Theodore C. Pierson  Cell 
Fei Xiao, Jane A. McKeating, Thomas F. Baumert  Journal of Hepatology 
Prevalence and Treatment of Hepatitis C Virus Genotypes 4, 5, and 6
Immigration and viral hepatitis
Cellular Networks Involved in the Influenza Virus Life Cycle
Silvia Affò, Ramón Bataller  Journal of Hepatology 
Anti−Hepatitis C Virus Drugs in Development
Simplified overview of the HCV life cycle and sites of direct acting antiviral therapies. Simplified overview of the HCV life cycle and sites of direct.
Pathogenesis of cholestatic hepatitis C
Assembly of infectious hepatitis C virus particles
Philippe Metz, Antje Reuter, Silke Bender, Ralf Bartenschlager 
Understanding How Hepatitis C Virus Builds Its Unctuous Home
T Cells Take on Zika Virus
Production and Biomedical Application of Flavivirus-like Particles
The hantavirus life cycle.
Presentation transcript:

Virology and cell biology of the hepatitis C virus life cycle – An update  Jean Dubuisson, François-Loïc Cosset  Journal of Hepatology  Volume 61, Issue 1, Pages S3-S13 (November 2014) DOI: 10.1016/j.jhep.2014.06.031 Copyright © 2014 European Association for the Study of the Liver Terms and Conditions

Fig. 1 HCV genome and proteins. HCV genome contains a single open reading frame flanked by 5′ and 3′ non-translated regions (NTRs). The 5′ NTR contains an internal ribosome entry site (IRES). After its synthesis, HCV polyprotein is cleaved by viral and host encoded proteases. Cleavage in the N-terminal part of the polyprotein is mediated by cellular signal peptidases as indicated by individual vertical arrows. An additional cleavage removing the carboxy-terminal region of the core protein is mediated by cellular signal peptide peptidase, as indicated by an open arrow. The linked arrows indicate the cleavages by the viral proteases NS2 and NS3/4A. The functions of the individual proteins are indicated at the bottom of the figure. Journal of Hepatology 2014 61, S3-S13DOI: (10.1016/j.jhep.2014.06.031) Copyright © 2014 European Association for the Study of the Liver Terms and Conditions

Fig. 2 HCV entry. The HCV virion is tightly associated with lipoproteins to form a complex particle that has been called lipoviroparticle. It initiates its life cycle by binding to glycosaminoglycans (GAGs) and SRB1. Then the virus follows a complex multistep process, involving a series of specific cellular entry factors, which include SRB1, CD81, tight-junction proteins, CLDN1 and OCLN, EGFR, transferrin receptor (TfR), and NPC1L1 as well as signaling proteins (see text for details). After binding to several components of the host cell, HCV particle is internalized by clathrin-mediated endocytosis and fusion takes place in early endosomes. Journal of Hepatology 2014 61, S3-S13DOI: (10.1016/j.jhep.2014.06.031) Copyright © 2014 European Association for the Study of the Liver Terms and Conditions

Fig. 3 HCV replication and assembly. Upon cleavage of the polyprotein, HCV non-structural proteins form the replication complex in association with cellular factors, which leads to the formation of double-membrane vesicles, also called the membranous web, where replication takes place. After cleavage of its C-terminus, core protein is loaded onto LDs. The junction between core-loaded LDs and the replication-complex-rich ER membranes is the site of virion assembly. Newly replicated viral genomes are transferred to the assembly sites via NS3/4A or NS5A, and NS2, and p7 connect replication complexes and core proteins to the glycoproteins. The next steps in HCV virion morphogenesis are tightly linked to the metabolism of VLDL assembly. However, the details of the intersection between HCV assembly and VLDL biogenesis remain poorly understood. It has been demonstrated that HCV particle contains apoE and neutral lipids, but how these components are acquired during HCV morphogenesis remains speculative, and this figure represents a hypothetical model. Journal of Hepatology 2014 61, S3-S13DOI: (10.1016/j.jhep.2014.06.031) Copyright © 2014 European Association for the Study of the Liver Terms and Conditions

Journal of Hepatology 2014 61, S3-S13DOI: (10.1016/j.jhep.2014.06.031) Copyright © 2014 European Association for the Study of the Liver Terms and Conditions